Preventing outbreaks and protecting at-risk patients
Accurate and fast results help prevent C. auris hospital outbreaks and can protect fragile patients from potentially deadly outcomes.
Operational efficency with simple workflow
Less chance for error with CLIA moderate complexity, no DNA extraction required.
Excellent clinical performance
High performance in clinical trials: 94.8% sensitivity (PPA) and 98.7% specificity (NPA).
Clinically impactful
Timely and accurate identification of patients with suspected C. auris colonization supports infection and prevention control strategies in healthcare settings.
